A 28-year-old woman from Kerala returns after a 2-week visit to a malaria-endemic region. She now presents with fever, headache, and confusion. Thick blood smear shows parasitemia of 8% with banana-shaped gametocytes and absence of stippling. She develops seizures and altered sensorium. What is the most appropriate immediate diagnostic and therapeutic approach?

Explanation

## Severe Malaria with Cerebral Involvement **Key Point:** High parasitemia (>5%), neurological symptoms (seizures, altered sensorium), and banana-shaped gametocytes indicate *P. falciparum* severe malaria with cerebral involvement. IV artesunate is the WHO-recommended first-line treatment for severe malaria and must be started immediately without waiting for diagnostic confirmation. ### Diagnostic and Clinical Features of Cerebral Malaria | Feature | Finding in This Case | Significance | |---------|----------------------|---------------| | **Parasitemia Level** | 8% | >5% indicates severe malaria | | **Gametocyte Morphology** | Banana-shaped | Pathognomonic for *P. falciparum* | | **Absence of Stippling** | Yes | Rules out *P. vivax*, *P. ovale* | | **Neurological Signs** | Seizures, altered sensorium | Cerebral malaria | | **Geographic Origin** | Kerala (endemic zone) | High transmission area | **High-Yield:** Cerebral malaria is a medical emergency with mortality >15% even with treatment. Every hour of delay in starting artesunate increases mortality risk. ### Management Algorithm for Severe Malaria ```mermaid flowchart TD A[Suspected Severe Malaria]:::outcome --> B{Parasitemia > 5% or<br/>Neurological/Renal/Metabolic<br/>complications?}:::decision B -->|Yes| C[Severe Malaria Confirmed]:::urgent C --> D[Start IV Artesunate<br/>IMMEDIATELY]:::action D --> E[Do NOT delay for<br/>diagnostic confirmation]:::urgent E --> F[Supportive care:<br/>manage seizures,<br/>cerebral edema,<br/>acidosis]:::action F --> G[Switch to oral ACT<br/>after 24 hrs if improving]:::action B -->|No| H[Uncomplicated Malaria]:::outcome H --> I[Oral artemisinin-based<br/>combination therapy]:::action ``` **Clinical Pearl:** Lumbar puncture is NOT contraindicated in cerebral malaria and may be needed to rule out concurrent meningitis, especially in endemic regions where co-infections occur. However, it should NOT delay IV artesunate initiation. **Warning:** ~~Chloroquine~~ and ~~quinine~~ are obsolete for severe malaria. Artesunate is superior in efficacy and safety. Quinine is associated with hypoglycemia and QT prolongation; it is no longer recommended as first-line therapy. **Mnemonic:** **SEVERE malaria = Start Artesunate Immediately, Verify later, Expect rapid response, Reduce mortality by 35%** ### Why IV Artesunate? 1. **Fastest parasite clearance:** Reduces parasitemia by 50% in <24 hours. 2. **Lower mortality:** 35% mortality reduction compared to quinine (WHO 2011 trial). 3. **No need for diagnostic delay:** Clinical suspicion + high parasitemia = treat immediately. 4. **Seizure management:** Concurrent anticonvulsants and supportive care are essential. [cite:Harrison 21e Ch 219; WHO Guidelines on Malaria 2023]